Market Cap 135.66B
Revenue (ttm) 22.60B
Net Income (ttm) 2.99B
EPS (ttm) N/A
PE Ratio 26.94
Forward PE 26.17
Profit Margin 13.25%
Debt to Equity Ratio 0.76
Volume 674,300
Avg Vol 1,672,812
Day's Range N/A - N/A
Shares Out 382.42M
Stochastic %K 46%
Beta 0.89
Analysts Strong Sell
Price Target $432.88

Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the t...

Industry: Medical Devices
Sector: Healthcare
Phone: (269) 385-2600
Fax: (269) 385-1062
Address:
1941 Stryker Way, Portage, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:26 PM
Actionable Trade Alert for $SYK: Market Context: $SYK is currently trading at $354.74, with a recent RSI of 35.48 indicating it is in oversold territory. The stock is below its 30-day (MA30) and 50-day (MA50) moving averages, suggesting bearish sentiment. However, the proximity to the 60-day low of $347.26 may provide a support level for a potential reversal. Directional Bias: Given the RSI and the current price near the 60D low, there is a potential for a bullish reversal. The ATR of 6.06 indicates volatility, allowing for significant price movement. Trade Plan: - Suggested Entry: $355.00 - Stop Loss: $347.00 (below the 60D low) - Take Profit Targets: 1. $365.00 (Target 1: 2.82% ROI) 2. $375.00 (Target 2: 5.69% ROI) 3. $415.00 (Target 3: 17% ROI) This trade plan capitalizes on a potential rebound while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Neahrain8
Neahrain8 Dec. 24 at 4:56 PM
0 · Reply
FemtoFinance
FemtoFinance Dec. 24 at 3:56 PM
$SYK Market re‑assessment is likely to follow discipline in balancing growth ambition with capital efficiency, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
ZacksResearch
ZacksResearch Dec. 24 at 12:35 PM
Intuitive Surgical vs. Stryker: Which MedTech Giant Has More Upside? 🤔 $ISRG offers a concentrated play on surgical robotics with high margins and strong recurring revenue growth. Its da Vinci platform is driving high-teens to 20% procedure growth! Meanwhile, $SYK provides diversified exposure with steady, but slower, growth. Discover why ISRG might offer greater upside today 👉 https://www.zacks.com/stock/news/2808389/intuitive-surgical-vs-stryker-which-medtech-stock-has-more-upside?cid=sm-stocktwits-2-2808389-body-26114&ADID=SYND_STOCKTWITS_TWEET_2_2808389_BODY_26114
0 · Reply
ZacksResearch
ZacksResearch Dec. 24 at 11:35 AM
$ISRG vs. $SYK — which MedTech name actually has more upside right now? Intuitive Surgical’s robotics-first model, recurring revenue base, and margin leverage clearly differentiate it from Stryker when it comes to upside potential today — the business mix matters here. 🤖📈 See the full breakdown of what separates these two MedTech giants 👉 https://www.zacks.com/stock/news/2808389/intuitive-surgical-vs-stryker-which-medtech-stock-has-more-upside?cid=sm-stocktwits-2-2808389-teaser-26112&ADID=SYND_STOCKTWITS_TWEET_2_2808389_TEASER_26112
0 · Reply
OptionRunners
OptionRunners Dec. 22 at 8:12 PM
$SYK buyer of the January 15th 2027 $350 puts 469 times for $26.18
0 · Reply
1iquid
1iquid Dec. 20 at 8:00 AM
OptionWizards Tip (education only): Evaluate implied volatility before trading options on SYK, UNP, or LOW to understand if premiums are unusually high or… $SYK $UNP $LOW Not financial advice.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:20 PM
Actionable Trade Alert for $SYK: Market Context: $SYK is currently trading at $353.11, showing weakness with an RSI of 25.59, indicating oversold conditions. The stock is below its 30-day (MA30) and 50-day (MA50) moving averages, which are at $361.42 and $365.46, respectively. The 60-day high of $392.55 and low of $347.26 suggests a potential for a rebound. Directional Bias: Given the oversold RSI and proximity to the 60-day low, there is a bullish bias for a short-term recovery. The ATR of 6.7 indicates moderate volatility, providing room for price movement. Trade Plan: - Suggested Entry: $355.00 (slightly above the last close) - Stop Loss: $347.00 (below the 60D low) - Take Profit Targets: 1. $365.00 (1st target, approx. 2.8% gain) 2. $375.00 (2nd target, approx. 5.6% gain) 3. $415.00 (3rd target, approx. 17.5% gain) This plan offers a potential ROI of over 17% on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
briefingcom
briefingcom Dec. 19 at 2:25 PM
$SYK: Stryker upgraded to Mkt Outperform from Mkt Perform at Citizens JMP; tgt $440 https://www.briefing.com/calendars/updown?Filter=upgrades&utm_campaign=updown&utm_medium=social&utm_source=st&utm_content=link
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 1:33 PM
Citizens has updated their rating for Stryker ( $SYK ) to Market Outperform with a price target of 440.
0 · Reply
Latest News on SYK
Stryker declares an $0.88 per share quarterly dividend

Dec 11, 2025, 8:00 AM EST - 16 days ago

Stryker declares an $0.88 per share quarterly dividend


Stryker Corporation (SYK) Analyst/Investor Day Transcript

Nov 19, 2025, 6:03 PM EST - 5 weeks ago

Stryker Corporation (SYK) Analyst/Investor Day Transcript


Why Stryker Stock May Be Headed For A Prolonged Slowdown

Nov 17, 2025, 7:48 AM EST - 5 weeks ago

Why Stryker Stock May Be Headed For A Prolonged Slowdown


Stryker: Strong Growth, But Valuation Is A Concern

Nov 4, 2025, 10:22 PM EST - 7 weeks ago

Stryker: Strong Growth, But Valuation Is A Concern


Stryker: Striking Again

Nov 3, 2025, 4:30 AM EST - 7 weeks ago

Stryker: Striking Again


Stryker Corporation (SYK) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 7:16 PM EDT - 2 months ago

Stryker Corporation (SYK) Q3 2025 Earnings Call Transcript


Stryker raises lower end of annual profit forecast

Oct 30, 2025, 7:04 PM EDT - 2 months ago

Stryker raises lower end of annual profit forecast


Stryker reports third quarter 2025 operating results

Oct 30, 2025, 4:05 PM EDT - 2 months ago

Stryker reports third quarter 2025 operating results


Stryker Launches Incompass Total Ankle System at AOFAS 2025

Sep 9, 2025, 7:20 AM EDT - 3 months ago

Stryker Launches Incompass Total Ankle System at AOFAS 2025


Stryker Q2: Record Mako Installation And High Utilization

Aug 19, 2025, 2:55 PM EDT - 4 months ago

Stryker Q2: Record Mako Installation And High Utilization


Stryker to host investor day

Aug 15, 2025, 8:00 AM EDT - 4 months ago

Stryker to host investor day


Stryker declares an $0.84 per share quarterly dividend

Aug 7, 2025, 8:00 AM EDT - 5 months ago

Stryker declares an $0.84 per share quarterly dividend


Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:59 PM EDT - 5 months ago

Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript


Stryker reports second quarter 2025 operating results

Jul 31, 2025, 4:05 PM EDT - 5 months ago

Stryker reports second quarter 2025 operating results


The Big 3: NXT, ANET, SYK

Jun 26, 2025, 1:01 PM EDT - 6 months ago

The Big 3: NXT, ANET, SYK

ANET NXT


Stryker receives FDA clearance for Incompass Total Ankle System

Jun 25, 2025, 8:15 AM EDT - 6 months ago

Stryker receives FDA clearance for Incompass Total Ankle System


The 3 Most Overvalued Stocks Top Managers Are Selling in 2025

Jun 3, 2025, 11:09 AM EDT - 7 months ago

The 3 Most Overvalued Stocks Top Managers Are Selling in 2025

MA NFLX


Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:28 PM EDT - 8 months ago

Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript


Stryker reports first quarter 2025 operating results

May 1, 2025, 4:05 PM EDT - 8 months ago

Stryker reports first quarter 2025 operating results


Stryker completes sale of U.S. spinal implants business

Apr 1, 2025, 4:05 PM EDT - 9 months ago

Stryker completes sale of U.S. spinal implants business


Stryker announces Annual Meeting of Shareholders

Mar 25, 2025, 4:15 PM EDT - 9 months ago

Stryker announces Annual Meeting of Shareholders


The Big 3: MMM, PM, SYK

Mar 18, 2025, 1:01 PM EDT - 10 months ago

The Big 3: MMM, PM, SYK

MMM PM


Stryker launches Steri-Shield 8 personal protection system

Mar 4, 2025, 8:07 AM EST - 10 months ago

Stryker launches Steri-Shield 8 personal protection system


Stryker launches Sync Badge

Mar 3, 2025, 8:07 AM EST - 10 months ago

Stryker launches Sync Badge


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:26 PM
Actionable Trade Alert for $SYK: Market Context: $SYK is currently trading at $354.74, with a recent RSI of 35.48 indicating it is in oversold territory. The stock is below its 30-day (MA30) and 50-day (MA50) moving averages, suggesting bearish sentiment. However, the proximity to the 60-day low of $347.26 may provide a support level for a potential reversal. Directional Bias: Given the RSI and the current price near the 60D low, there is a potential for a bullish reversal. The ATR of 6.06 indicates volatility, allowing for significant price movement. Trade Plan: - Suggested Entry: $355.00 - Stop Loss: $347.00 (below the 60D low) - Take Profit Targets: 1. $365.00 (Target 1: 2.82% ROI) 2. $375.00 (Target 2: 5.69% ROI) 3. $415.00 (Target 3: 17% ROI) This trade plan capitalizes on a potential rebound while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Neahrain8
Neahrain8 Dec. 24 at 4:56 PM
0 · Reply
FemtoFinance
FemtoFinance Dec. 24 at 3:56 PM
$SYK Market re‑assessment is likely to follow discipline in balancing growth ambition with capital efficiency, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
ZacksResearch
ZacksResearch Dec. 24 at 12:35 PM
Intuitive Surgical vs. Stryker: Which MedTech Giant Has More Upside? 🤔 $ISRG offers a concentrated play on surgical robotics with high margins and strong recurring revenue growth. Its da Vinci platform is driving high-teens to 20% procedure growth! Meanwhile, $SYK provides diversified exposure with steady, but slower, growth. Discover why ISRG might offer greater upside today 👉 https://www.zacks.com/stock/news/2808389/intuitive-surgical-vs-stryker-which-medtech-stock-has-more-upside?cid=sm-stocktwits-2-2808389-body-26114&ADID=SYND_STOCKTWITS_TWEET_2_2808389_BODY_26114
0 · Reply
ZacksResearch
ZacksResearch Dec. 24 at 11:35 AM
$ISRG vs. $SYK — which MedTech name actually has more upside right now? Intuitive Surgical’s robotics-first model, recurring revenue base, and margin leverage clearly differentiate it from Stryker when it comes to upside potential today — the business mix matters here. 🤖📈 See the full breakdown of what separates these two MedTech giants 👉 https://www.zacks.com/stock/news/2808389/intuitive-surgical-vs-stryker-which-medtech-stock-has-more-upside?cid=sm-stocktwits-2-2808389-teaser-26112&ADID=SYND_STOCKTWITS_TWEET_2_2808389_TEASER_26112
0 · Reply
OptionRunners
OptionRunners Dec. 22 at 8:12 PM
$SYK buyer of the January 15th 2027 $350 puts 469 times for $26.18
0 · Reply
1iquid
1iquid Dec. 20 at 8:00 AM
OptionWizards Tip (education only): Evaluate implied volatility before trading options on SYK, UNP, or LOW to understand if premiums are unusually high or… $SYK $UNP $LOW Not financial advice.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:20 PM
Actionable Trade Alert for $SYK: Market Context: $SYK is currently trading at $353.11, showing weakness with an RSI of 25.59, indicating oversold conditions. The stock is below its 30-day (MA30) and 50-day (MA50) moving averages, which are at $361.42 and $365.46, respectively. The 60-day high of $392.55 and low of $347.26 suggests a potential for a rebound. Directional Bias: Given the oversold RSI and proximity to the 60-day low, there is a bullish bias for a short-term recovery. The ATR of 6.7 indicates moderate volatility, providing room for price movement. Trade Plan: - Suggested Entry: $355.00 (slightly above the last close) - Stop Loss: $347.00 (below the 60D low) - Take Profit Targets: 1. $365.00 (1st target, approx. 2.8% gain) 2. $375.00 (2nd target, approx. 5.6% gain) 3. $415.00 (3rd target, approx. 17.5% gain) This plan offers a potential ROI of over 17% on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
briefingcom
briefingcom Dec. 19 at 2:25 PM
$SYK: Stryker upgraded to Mkt Outperform from Mkt Perform at Citizens JMP; tgt $440 https://www.briefing.com/calendars/updown?Filter=upgrades&utm_campaign=updown&utm_medium=social&utm_source=st&utm_content=link
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 1:33 PM
Citizens has updated their rating for Stryker ( $SYK ) to Market Outperform with a price target of 440.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 4:03 PM
Truist Securities updates rating for Stryker ( $SYK ) to Hold, target set at 400 → 392.
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 17 at 2:45 AM
A List of Robotics Stocks: Healthcare Robotics $ISRG Intuitive Surgical $SYK Stryker $MDT Medtronic $ARAY Accuray $PRCT PROCEPT
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:07 AM
Actionable Trade Alert for $SYK: Market Context: $SYK is currently trading at $352.44, with a significant RSI of 20.78 indicating it is oversold, suggesting a potential reversal. The stock is below its moving averages (MA30 at 361.93 and MA50 at 366.25), which typically indicates bearish sentiment, but the low RSI signals a possible buying opportunity. Directional Bias: Given the current low RSI and proximity to the 60D low of $347.26, we anticipate a bullish reversal towards the 60D high of $392.55. Trade Plan: - Suggested Entry: $352.44 - Stop Loss: $342.44 (10 points below entry) - Take Profit Targets: - TP1: $362.44 (3% gain) - TP2: $372.44 (5.7% gain) - TP3: $412.44 (17% gain) This trade plan aims for a substantial return, leveraging the oversold condition and potential upward movement towards the resistance levels. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
richard74
richard74 Dec. 16 at 6:14 PM
$SYK Adding here!
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Dec. 16 at 2:25 PM
$SYK $TEM $GEHC Tempus has a projected earnings growth rate of 58.9% for 2025, higher than the industry’s 37% growth. The company has a favorable current cashflow rate of 267.2% against the industry’s 28.3%. TEM has a projected sales growth rate of 82.2% (for the current fiscal year) compared with the industry’s 3.6% growth
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 1:38 PM
AI Revolution in MedTech: What It Means for $SYK, $TEM & $GEHC 🚀 AI is transforming MedTech, from R&D to diagnostics, with startups and giants like Stryker, Tempus AI, and GE HealthCare leading the charge. These companies are leveraging AI for smarter operations, enhanced diagnostics, and improved patient care, setting the stage for future growth. Discover what makes these players stand out in the AI-driven MedTech landscape https://www.zacks.com/stock/news/2804794/3-medtech-stocks-poised-to-gain-in-2026-from-the-ai-boom?cid=sm-stocktwits-2-2804794-body-24930&ADID=SYND_STOCKTWITS_TWEET_2_2804794_BODY_24930
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 12:38 PM
AI is coming for MedTech — and these 3 names could be the 2026 winners 🚀 AI is reshaping MedTech, with $SYK, $TEM, and $GEHC emerging as key players applying AI across surgery, diagnostics, and imaging—the core of modern healthcare innovation. Want to see how the AI boom could fuel gains into 2026? Full breakdown here 👉 https://www.zacks.com/stock/news/2804794/3-medtech-stocks-poised-to-gain-in-2026-from-the-ai-boom?cid=sm-stocktwits-2-2804794-teaser-24929&ADID=SYND_STOCKTWITS_TWEET_2_2804794_TEASER_24929
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 5:41 AM
Actionable Trade Alert for $SYK: Market Context: $SYK closed at $354.09, currently in a bearish trend with an RSI of 32.9 indicating oversold conditions. The price is below both the 30-day MA (362.15) and the 50-day MA (366.83), suggesting continued downward pressure. However, the proximity to the 60-day low of 347.26 may offer a potential reversal point. Directional Bias: Given the oversold RSI and the price nearing the 60-day low, we anticipate a potential bounce back. This aligns with historical price behavior near lows. Trade Plan: - Suggested Entry: $354.09 (last close) - Stop Loss: $347.00 (below 60D low) - Take Profit Targets: 1. $362.00 (MA30 resistance) - 2.2% ROI 2. $370.00 (psychological level) - 4.5% ROI 3. $415.00 (17.2% ROI, 60D high) This plan provides a clear path for potential recovery with a strong upside. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
DividendPower
DividendPower Dec. 13 at 12:27 PM
Recent Dividend Increases - Updated 12/12/25 https://www.dividendpower.org/dividend-increases/ $MA $SYK $GGG $ANDE $AMGN
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 10:34 PM
Actionable Trade Alert for $SYK: Market Context: $SYK is currently trading at $355.12, which is near the lower end of its 60-day range (347.26 - 392.55). The RSI at 44.49 indicates a neutral sentiment, suggesting potential for upward movement. The price is below both the 30-day MA (362.72) and the 50-day MA (367.12), indicating bearish pressure but also presenting a buying opportunity if it breaks above these levels. Directional Bias: The recent price action suggests a potential reversal as it approaches the 60-day low. A break above the 30-day MA could signal a shift in momentum. Trade Plan: - Suggested Entry: $357.00 (break above MA30) - Stop Loss: $348.00 (below recent support) - Take Profit Targets: 1. $370.00 (1st target, approx. 3.6% ROI) 2. $380.00 (2nd target, approx. 6.9% ROI) 3. $416.00 (3rd target, approx. 17% ROI) Monitor price action closely, especially around MA levels. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:06 PM
Citigroup has adjusted their stance on Stryker ( $SYK ), setting the rating to Buy with a target price of 455 → 420.
0 · Reply
EvelynHarmon
EvelynHarmon Dec. 10 at 9:51 PM
$SYK ending the day stable with constructive action
0 · Reply